SIL INDEX IS A SIMPLE AND OBJECTIVE PROGNOSTIC INDICATOR IN DIFFUSE LARGE B-CELL LYMPHOMA

被引：0
|
作者：
Tomita, N. [1 ]
Suzuki, T. [2 ]
Miyashita, K. [3 ]
Yamamoto, W. [4 ]
Motohashi, K. [5 ]
Tachibana, T. [1 ]
Takasaki, H. [4 ]
Kawasaki, R. [3 ]
Hagihara, M. [5 ]
Hashimoto, C. [6 ]
Takemura, S. [7 ]
Koharazawa, H. [8 ]
Yamazaki, E. [1 ]
Taguchi, J. [8 ]
Fujimaki, K. [3 ]
Fujita, H. [9 ]
Sakai, R. [4 ]
Fujisawa, S. [5 ]
Motomura, S. [4 ]
Ishigatsubo, Y. [1 ]
机构：
[1] Yokohama City Univ, Grad Sch Med, Internal Med & Clin Immunol, Yokohama, Kanagawa 232, Japan
[2] Yokosuka City Hosp, Hematol, Yokosuka, Kanagawa, Japan
[3] Fujisawa City Hosp, Hematol Immunol, Fujisawa, Kanagawa, Japan
[4] Kanagawa Canc Ctr, Med Oncol, Yokohama, Kanagawa 2410815, Japan
[5] Yokohama City Univ, Hematol, Med Ctr, Yokohama, Kanagawa 232, Japan
[6] Yamato Municipal Hosp, Hematol Oncol, Yamato, Japan
[7] Yokohama Ekisaikai Hosp, Internal Med, Yokohama, Kanagawa, Japan
[8] Shizuoka Red Cross Hosp, Hematol, Shizuoka, Japan
[9] Saiseikai Yokohama Nanbu Hosp, Hematol, Yokohama, Kanagawa, Japan
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E970
引用
收藏
页码：388 / 388
页数：1
相关论文
共 50 条
  • [31] PROPOSAL OF NEW PROGNOSTIC INDEX FOR PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN THE RITUXIMAB ERA
    Yoon, S.
    Yoon, D. H.
    Kim, S.
    Lee, K.
    Kang, E. H.
    Lee, S. W.
    Park, C. J.
    Park, C. S.
    Huh, J.
    Suh, C.
    HAEMATOLOGICA, 2015, 100 : 403 - 404
  • [32] Prognostic significance of the modified Barthel index in elderly patients with diffuse large B-cell lymphoma
    Ogura, Shinji
    Nakazato, Tomonori
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 75 : 110 - 111
  • [33] Prognostic Impact of Skeletal Muscle Index and Vitamin D in Diffuse Large B-Cell Lymphoma
    Nakamura, Nobuhiko
    Kanemura, Nobuhiro
    Shimazu, Ryoma
    Goto, Takayuki
    Kaneda, Yuto
    Ikoma, Yoshikazu
    Matsumoto, Takuro
    Nakamura, Hiroshi
    Shimizu, Masahito
    BLOOD, 2023, 142
  • [34] Proposal of New Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Yoon, Shinkyo
    Yoon, Dok Hyun
    Kim, Shin
    Lee, Kyoungmin
    Kang, Eun Hee
    Lee, Sang-wook
    Park, Chan-Jeoung
    Park, Chan-Sik
    Huh, Jooryung
    Suh, Cheolwon
    BLOOD, 2014, 124 (21)
  • [35] Expression of SATB1 is a prognostic indicator for survival in diffuse large B-cell lymphoma patients
    Yi, H.
    Wei, Y.
    Chen, J-J
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (02) : 382 - 390
  • [36] Baseline renal function as a prognostic indicator in patients with newly diagnosed diffuse large B-cell lymphoma
    Hong, Junshik
    Lee, Sojung
    Chun, Gayoung
    Jung, Ji Yong
    Park, Jinny
    Ahn, Jeong Yeal
    Cho, Eun Kyung
    Shin, Dong Bok
    Lee, Jae Hoon
    BLOOD RESEARCH, 2016, 51 (02) : 113 - 121
  • [37] Prognostic markers and angiogenesis in diffuse large B-cell lymphoma and follicular lymphoma
    Mezei, T.
    Gurzu, S.
    Raica, M.
    Cimpean, A.
    Szentirmay, J.
    Jung, J.
    VIRCHOWS ARCHIV, 2009, 455 : 17 - 18
  • [38] Secondary Cutaneous Diffuse Large B-cell Lymphoma has a Higher International Prognostic Index Score and Worse Prognosis Than Diffuse Large B-cell Lymphoma, Leg Type
    Lee, Woo Jin
    Won, Kwang Hee
    Won, Chong Hyun
    Chang, Sung Eun
    Choi, Jee Ho
    Moon, Kee Chan
    Park, Chan-Sik
    Huh, Jooryung
    Suh, Cheolwon
    Lee, Mi Woo
    ACTA DERMATO-VENEREOLOGICA, 2016, 96 (02) : 245 - 250
  • [39] Diffuse large B-cell lymphoma
    Barraclough, Allison
    Hawkes, Eliza
    Sehn, Laurie H.
    Smith, Sonali M.
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (06)
  • [40] Diffuse Large B-Cell Lymphoma
    Sehn, Laurie H.
    Salles, Gilles
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (09): : 842 - 858
12345